Full Text View
Tabular View
No Study Results Posted
Related Studies
Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson
This study has been completed.
Study NCT00881218   Information provided by Washington University School of Medicine

First Received on April 13, 2009.   Last Updated on April 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ischemic Heart Disease
Additional conditions recognized in this trial
Coronary Artery Disease
Heart Diseases
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Coronary Disease
Vascular Diseases
Interventions listed in this trial
Regadenoson
More general drug interventions related to this trial
Adenosine A2 Receptor Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Purinergic Agents
Purinergic Antagonists
Purinergic P1 Receptor Antagonists
Sponsors listed in this trial
Washington University School of Medicine
Astellas Pharma US, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services